Is Lo Loestrin (ethinyl estradiol and norethindrone acetate) a suitable birth control option?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lo Loestrin Fe: A Suitable Birth Control Option with Low Estrogen Dose

Lo Loestrin Fe (ethinyl estradiol 10 μg and norethindrone acetate 1 mg) is a suitable birth control option for most women due to its low estrogen dose, which minimizes cardiovascular risks while maintaining contraceptive efficacy.

Efficacy and Composition

Lo Loestrin Fe is a combined oral contraceptive (COC) containing:

  • 10 μg of ethinyl estradiol (one of the lowest estrogen doses available)
  • 1 mg of norethindrone acetate (a first-generation progestin)

This low-dose formulation offers:

  • High contraceptive efficacy when used correctly (perfect use failure rate of 0.3%) 1
  • Typical use failure rate of approximately 5-9% (comparable to other COCs) 2
  • 24-day active hormone regimen with 4-day placebo/iron supplement phase

Benefits

Lo Loestrin Fe provides several benefits:

  • Reduced cardiovascular risk due to its ultra-low estrogen dose (10 μg) compared to standard low-dose pills (20-35 μg) 3
  • Shorter, lighter periods or even amenorrhea for some users 4
  • Non-contraceptive benefits including:
    • Decreased menstrual cramping and blood loss
    • Improvement in acne (though less pronounced than with higher estrogen formulations) 3, 1
    • Decreased risk of endometrial and ovarian cancers with long-term use 1
    • Reduced risk of anemia due to lighter menstrual bleeding 1

Safety Profile

The safety profile of Lo Loestrin Fe is favorable compared to higher-dose COCs:

  • Lower venous thromboembolism (VTE) risk compared to higher estrogen formulations:

    • Baseline VTE risk (non-users): 1-5 per 10,000 woman-years
    • Lo Loestrin Fe (10 μg EE): Likely at the lower end of the COC risk spectrum of 3-9 per 10,000 woman-years 3
    • For context: Pregnancy VTE risk is 5-20 per 10,000 woman-years 3, 1
  • Blood pressure effects: Lower estrogen dose is associated with smaller increases in blood pressure compared to higher-dose formulations 3

Potential Drawbacks

Despite its benefits, Lo Loestrin Fe has some potential drawbacks:

  • Breakthrough bleeding: More common with ultra-low dose formulations, especially during the first few cycles 4
  • Strict adherence required: Must be taken at the same time daily for maximum effectiveness
  • No STI protection: Condoms still needed for protection against sexually transmitted infections
  • Drug interactions: Effectiveness may be reduced by certain medications (antibiotics, anticonvulsants, antiretrovirals) 3, 1

Who Should Consider Lo Loestrin Fe

Lo Loestrin Fe may be particularly suitable for:

  • Women concerned about estrogen-related side effects
  • Those with risk factors that make higher estrogen doses problematic:
    • History of mild hypertension
    • Migraine without aura
    • Age >35 years (but without other cardiovascular risk factors)
  • Women who experienced side effects with higher-dose COCs

Contraindications

Lo Loestrin Fe is contraindicated in women with:

  • History of or current venous thromboembolism 3, 1
  • Severe hypertension 3, 1
  • Migraine with aura 3, 1
  • Breast cancer 1
  • Liver disease 1
  • Smoking at age 35 or older 3
  • Multiple cardiovascular risk factors 3, 1

Alternative Options to Consider

For women with contraindications to combined hormonal contraceptives:

  • Progestin-only methods: Pills, implants, or injections 3
  • Non-hormonal IUDs: Copper IUDs have no increased thrombotic risk 1
  • Barrier methods: Condoms, diaphragms (though less effective than hormonal methods) 2

Conclusion

Lo Loestrin Fe represents one of the lowest estrogen dose combined oral contraceptives available, offering a favorable balance between efficacy and safety for most women. Its ultra-low estrogen content minimizes estrogen-related side effects and risks while maintaining contraceptive effectiveness, making it a good option for women seeking hormonal contraception with minimal estrogen exposure.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.